FDA Approved: MESALAMINE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved Actavis Pharma, Inc.'s original ANDA for mesalamine, a generic version of the anti-inflammatory drug used to treat ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)